Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine vs atenolol in chronic stable angina (China phase III)
CTR20140360Phase 3Active
- Sponsor
- Chongqing Lummy Pharmaceutical
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ivabradine in angina pectoris, coronary arteriosclerosis, sponsored by Chongqing Lummy Pharmaceutical. Started Jun 2014; status: active.
02
Drugs
ivabradine
03
Conditions
angina pectoriscoronary arteriosclerosis
Beyond the preview
Go deeper on CTR20140360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140360.